TGFBR2 and neoplasm: Interestingly, the results showed that low TGFBR2 expression was significantly negatively correlated with FIGO stage, differentiation grade, pelvic lymph node metastasis, recurrence, and vital status (P < 0.05), but no significant association was observed between TGFBR2 expression and other clinicopathologic features, such as age, abortion, menopausal status, tumor size, histological type, vaginal invasion, parametrial infiltration, and adjuvant radiotherapy (P > 0.05).